Corcept Therapeutics
CORT
#2078
Rank
NZ$15.70 B
Marketcap
NZ$149.05
Share price
1.71%
Change (1 day)
47.55%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$1.09 Billion

According to Corcept Therapeutics 's latest financial reports the company has NZ$1.09 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$1.20 B50.39%
2023-12-31$NZ$0.80 B1.37%
2022-12-31$NZ$0.79 B43.66%
2021-12-31$NZ$0.55 B-24.14%
2020-12-31$NZ$0.72 B31.6%
2019-12-31$NZ$0.55 B34%
2018-12-31$NZ$0.41 B52.96%
2017-12-31$NZ$0.26 B350.13%
2016-12-31$NZ$59.73 M121.02%
2015-12-31$NZ$27.02 M-725.04%
2014-12-31$-NZ$4.33 Million-116.91%
2013-12-31$NZ$25.57 M-65.94%
2012-12-31$NZ$75.09 M68.38%
2011-12-31$NZ$44.59 M61.96%
2010-12-31$NZ$27.53 M-9.47%
2009-12-31$NZ$30.41 M4.4%
2008-12-31$NZ$29.13 M51.46%
2007-12-31$NZ$19.23 M113.07%
2006-12-31$NZ$9.02 M-76.8%
2005-12-31$NZ$38.9 M-39.58%
2004-12-31$NZ$64.39 M-233%
2003-12-31$-NZ$48.42 Million15.49%
2002-12-31$-NZ$41.93 Million-177.8%
2001-12-31$NZ$53.88 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$137.22 B 12,445.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B 2,843.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$77.46 B 6,982.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$41.28 B 3,674.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 14,632.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.85 B 8,114.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$0.79 Billion-171.43%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$77.12 Million-107.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$10.48 B 858.49%๐Ÿ‡บ๐Ÿ‡ธ USA